Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

E. Cem Atbasoglu, Guvem Gumus-Akay, Sinan Guloksuz, Meram Can Saka, Alp Ucok, Koksal Alptekin, Sevim Gullu, Jim van Os

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1029-1039
Number of pages11
JournalPsychopharmacology
Volume235
Issue number4
DOIs
Publication statusPublished - 1 Apr 2018

Keywords

  • Dopamine
  • Genetics
  • Insulin resistance
  • Schizophrenia
  • Schizotypy
  • Type 2 diabetes mellitus
  • DRUG-NAIVE PATIENTS
  • 1ST-EPISODE SCHIZOPHRENIA
  • NEUROTROPHIC FACTOR
  • SPECTRUM DISORDERS
  • INSULIN-RESISTANCE
  • PSYCHOTIC DISORDER
  • DIABETES-MELLITUS
  • GLUCOSE-TOLERANCE
  • METAANALYSIS
  • DOPAMINE

Cite this

Atbasoglu, E. C., Gumus-Akay, G., Guloksuz, S., Saka, M. C., Ucok, A., Alptekin, K., Gullu, S., & van Os, J. (2018). Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia. Psychopharmacology, 235(4), 1029-1039. https://doi.org/10.1007/s00213-017-4818-z